Circle Road Advisors’s GSK GSK Stock Holding History

Circle Road Advisors’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-51,814	Closed	-$3.04M	–	5
2019 Q4	$3.04M	Sell	51,814 -40,929	-44%	-$2.28M	10.97%	3
2019 Q3	$4.95M	Buy	92,743 +50,321	+119%	+$2.59M	8.08%	4
2019 Q2	$2.12M	Sell	42,422 -70,364	-62%	-$3.53M	3.1%	15
2019 Q1	$5.89M	Sell	112,786 -104,486	-48%	-$5.22M	6.37%	8
2018 Q4	$10.4M	Buy	217,272 +59,826	+38%	+$2.95M	9.87%	1
2018 Q3	$7.91M	Buy	157,446 +4,046	+3%	+$206K	7.18%	6
2018 Q2	$7.73M	Sell	153,400 -21,590	-12%	-$1.09M	7.05%	6
2018 Q1	$8.55M	Buy	+174,990	New	+$8.15M	7%	4

Other funds holding GSK

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return

Circle Road Advisors's GSK Position: Q1 2020 in Review

Circle Road Advisors sold out of GSK (GSK) in Q1 2020, closing a stake of 51,814 shares — an estimated $3.04M sold.

Circle Road Advisors first reported a position in GSK in Q1 2018 and held it in 8 quarters. The position peaked at $10.4M in Q4 2018. 818 funds tracked by Wall St. Rank hold GSK as of Q1 2020.

Circle Road Advisors reported no remaining GSK position as of Q1 2020 after selling out during the quarter.
Circle Road Advisors sold 51,814 GSK shares in Q1 2020, an estimated $3.04M.
Circle Road Advisors first reported a position in GSK in Q1 2018 and held it in 8 quarters.
Circle Road Advisors's GSK position peaked at $10.4M in Q4 2018.
818 funds tracked by Wall St. Rank held GSK as of Q1 2020.

Based on Circle Road Advisors's 13F filing for Q1 2020.